Company
Inogen
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
3
510(k), De Novo and PMA
Device trials
5
As lead sponsor, any status
Adverse event reports
415
Received Nov 1, 2025 to Nov 19, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.
Listed
INGN
Nasdaq · Inogen Inc
Public float
$190M
Value of shares held by non-insiders on Jun 30, 2025
Revenue
$349M
Fiscal year ending Dec 31, 2025
Net income
-$22.7M
Fiscal year ending Dec 31, 2025
R&D spending
$19.4M
Fiscal year ending Dec 31, 2025
Cash
$81.8M
As of Sep 30, 2026
Long-term debt
Not reported
Shares outstanding
26.0M
As of Oct 29, 2026
Capital raised as a public company
Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.
| Year | IPO | Stock sold | Long-term debt | Convertible debt |
|---|---|---|---|---|
| 2025 | – | $27.2M | – | – |
Private placements (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Feb 16, 2010 | Equity | $9.6M | $10.0M | 8 | Rule 506 | Form D/A ↗Jul 13, 20101 amendment |
Company details
From the company's latest Form D.
- Legal name
- Inogen Inc
- Headquarters
- Goleta, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1294133 ↗
Executives, directors and promoters
As listed on the latest Form D.
6 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
K241091 · Decided Dec 23, 2024 · 245 days after receipt
Device type: Intra-Pulmonary Percussive Vibration (Ipv) Devices (SDT) · Anesthesiology & Respiratory
- Inogen Rove 6510(k)
K230052 · Decided Jun 30, 2023 · 175 days after receipt
Device type: Generator, Oxygen, Portable (CAW) · Anesthesiology & Respiratory
K222086 · Decided Dec 9, 2022 · 147 days after receipt
Device type: Generator, Oxygen, Portable (CAW) · Anesthesiology & Respiratory
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Simeox 200 US StudyNot yet recruiting
NCT07443124 · 35 participants (planned) · Start Feb 2026 · Primary completion May 2026
Device: Intermittent intrapulmonary deflation · For: Bronchiectasis; Mucus; Plug
Sites: Charleston, South Carolina
NCT06555484 · 40 participants · Start May 28, 2024 · Primary completion Oct 31, 2024
Device: Cross Over Assignment Supplemental Oxygen and Supplemental Air · For: Cognition
Sites: Philadelphia, Pennsylvania
NCT06000332 · 20 participants · Start Oct 17, 2023 · Primary completion Dec 21, 2023
Device: InogenOne Rove 6 Portable Oxygen Concentrator · For: Nocturnal Hypoxemia
Sites: Statesville, North Carolina
2 more trials with a free account
Reports received
415
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
31
7.5% of reports
Injury reports
380
92% of reports
Death reports
4
1.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 5 | 1 | 0 | 0 |
| Jan 24 | 7 | 1 | 0 | 0 |
| Feb 24 | 4 | 2 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 2 | 0 | 0 | 0 |
| Jul 24 | 25 | 1 | 2 | 0 |
| Aug 24 | 10 | 0 | 0 | 0 |
| Sep 24 | 5 | 0 | 0 | 0 |
| Oct 24 | 6 | 0 | 1 | 0 |
| Nov 24 | 7 | 0 | 0 | 0 |
| Dec 24 | 6 | 0 | 0 | 0 |
| Jan 25 | 7 | 0 | 2 | 0 |
| Feb 25 | 11 | 0 | 0 | 0 |
| Mar 25 | 47 | 4 | 0 | 0 |
| Apr 25 | 2 | 16 | 0 | 0 |
| May 25 | 0 | 8 | 0 | 0 |
| Jun 25 | 1 | 21 | 0 | 0 |
| Jul 25 | 1 | 18 | 0 | 0 |
| Aug 25 | 11 | 11 | 0 | 0 |
| Sep 25 | 1 | 11 | 0 | 0 |
| Oct 25 | 3 | 11 | 0 | 0 |
| Nov 25 | 1 | 19 | 0 | 0 |
| Dec 25 | 0 | 11 | 0 | 0 |
| Jan 26 | 1 | 19 | 0 | 0 |
| Feb 26 | 0 | 14 | 1 | 0 |
| Mar 26 | 1 | 35 | 1 | 0 |
| Apr 26 | 4 | 46 | 0 | 0 |
| May 26 | 0 | 28 | 0 | 0 |
| Jun 26 | 2 | 32 | 1 | 0 |
| Jul 26 | 3 | 41 | 0 | 0 |
| Aug 26 | 11 | 42 | 0 | 0 |
| Sep 26 | 3 | 41 | 0 | 0 |
| Oct 26 | 5 | 52 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Portable Oxygen GeneratorTerminated
Z-1368-05 · Started Aug 1, 2005 · Posted by FDA Aug 12, 2005
Reason given: Firm plans to upgrade all units to correct situations that could lead to interuption in oxygen delivery.
Cause as FDA categorized it: Other · Device type: Generator, Oxygen, Portable (CAW)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.